For laboratory research use only. Not for human or animal consumption.
Research-use material
GH SecretagoguesCJC-1295 no DAC5mg
$79
A short-acting GHRH analog studied for pulse-style growth-hormone and IGF-1 signaling.
Need 10 or more? Email info@curo.you for bulk pricing.
- $9.99 $0
- Ships on business days.
- Free standard shipping over $200. Expedited options available at checkout.
- Secure checkout.
Research overview
CJC-1295 no DAC, often discussed as Modified GRF(1-29), is a short-acting analog of GHRH, the hypothalamic signal that prompts growth-hormone release. Without the Drug Affinity Complex used in the longer-acting DAC form, research interest centers on a brief GHRH signal rather than a prolonged exposure window.
Research centers on growth-hormone and downstream IGF-1 signaling while preserving a more pulse-style profile. It is commonly studied in growth-hormone-axis models, recovery and body-composition research, and models where a GHRH-plus-secretagogue signal is the research target.
Dedicated controlled data on the no-DAC variant remains limited, and much of the published CJC-1295 literature focuses on the DAC-bearing form. That keeps the no-DAC version investigational and distinct from approved therapies.
Every lot ships with an independent certificate of analysis. Read how Curo tests every lot.
Storage quick reference
Protect from light. Keep all vials and bacteriostatic water away from direct sunlight and minimize other light exposure.
From the Curo library
Selected research
Reviews
CJC-1295 came quick. I had trouble finding something on the COA at first so I called support and they explained it right away. Good people.
Related research materials
CJC-1295 no DAC + Ipamorelin
This set includes one CJC-1295 no DAC compound and one Ipamorelin compound. Each compound is packaged separately and is not pre-mixed.
A GHRH-analog and selective-secretagogue pairing, studied together for a larger combined growth-hormone pulse than either compound produces alone.